Word: bidding
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...recently quoted in your story "Soaring Ambitions" [May 3] and felt it necessary to clarify the context of my remark about the current architectural boom in China. Emerging cultures like China often look to foreign firms to provide expertise and vision, and to lend weight to their bid for global presence. As such, they are very open to new ideas. The important point to emphasize is that plenty of these foreign firms are building remarkably innovative and responsible buildings, as Skidmore, Owings & Merrill has done for many decades, and that this represents an extraordinary opportunity for us as architects. That...
...studios to bid their rebate up to $20 per student, there would be no need to raise the book price. McGrath said his payments to HYP are top-level, but he did not indicate that they are the highest of any college he works with. Raising the rebate to $20 per student would net an additional $7,000—or $7,500 if the number of photo sittings rose...
...only way we can lose is if we're lazy or dumb and we don't do what we're supposed to do." BILL CLINTON, at a fund raiser in Harlem, encouraging attendees to support Senator John Kerry's bid for the presidency...
Jantzen had originally planned on competing in the Las Vegas trials, but was unable to participate due to scheduling conflicts with schoolwork. And though he tried to petition to get into the Olympic trials, his bid failed and he has been forced to wait at home...
...French are very territorial when it comes to champagne, ski resorts and, yes, pharmaceutical companies, which helps explain why the government strong-armed Sanofi-Synthelabo into sweetening a hostile bid for the Strasbourg-based Aventis--to create a French "national champion" in the pill market--and why the government warned Swiss drugmaker Novartis to stop fishing in the Rhine. Sanofi-Aventis will be the world's third largest pharmaceutical firm, after Pfizer and GlaxoSmithKline. But since the merger announcement, Sanofi's shares have tumbled, in part because investors think $66 billion is too high a price for Aventis, whose...